Kasprzak Lidia, Mesurolle Benoit, Tremblay Francine, Galvez Maria, Halwani Fawaz, Foulkes William D
Department of Medicine, McGill University Health Centre, Montreal, Canada.
World J Surg Oncol. 2005 Aug 4;3:52. doi: 10.1186/1477-7819-3-52.
Primary prevention of breast cancer through prophylactic mastectomy can reduce the risk of malignancy in high-risk individuals. No type of mastectomy completely removes all breast tissue, but a subcutaneous mastectomy leaves more tissue in situ than does a simple mastectomy.
We report a case of invasive breast cancer in a BRCA2-positive woman 33 years after bilateral subcutaneous mastectomy. To our knowledge, only one case of primary breast cancer after prophylactic mastectomy in a BRCA1-positive patient has been reported in the literature and none in BRCA2-positive individuals.
Careful documentation and long follow-up is essential to fully assess the benefits and risks of preventive surgical procedures in BRCA1 and BRCA2 mutation carriers.